1. A small-molecule inhibitor of the Wnt pathway (SM04690) as a potential disease modifying agent for the treatment of osteoarthritis of the knee. Issue 1 (January 2018) Authors: Deshmukh, V.; Hu, H.; Barroga, C.; Bossard, C.; KC, S.; Dellamary, L.; Stewart, J.; Chiu, K.; Ibanez, M.; Pedraza, M.; Seo, T.; Do, L.; Cho, S.; Cahiwat, J.; Tam, B.; Tambiah, J.R.S.; Hood, J.; Lane, N.E.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 26:Issue 1(2018) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-inflammatory Properties of SM04690, a Small Molecule Inhibitor of the Wnt Pathway as a Potential Treatment for Knee Osteoarthritis. (April 2017) Authors: Deshmukh, V.; Barroga, C.; Ibanez, M.; Seo, T.; KC, S.; Dellamary, L.; Stewart, J.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery of a small molecule inhibitor of the Wnt pathway (SM04690) as a potential treatment for degenerative disc disease. (April 2017) Authors: Barroga, C.; Deshmukh, V.; KC, S.; Dellamary, L.; Hood, J.; Steward, J.; Hu, H.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discovery of a Small Molecule Inhibitor of The Wnt Pathway (SM04755) as a Potential Topical Treatment for Tendinopathy. (April 2017) Authors: Deshmukh, V.; Seo, T.; Ibanez, M.; Hofilena, B.; KC, S.; Dellamary, L.; Stewart, J.; Hood, J.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Experimental tendinopathy treatment with SM04755, a topical small molecule inhibitor of the WNT pathway. (April 2018) Authors: Deshmukh, V.; Seo, T.; Hofilena, B.; Dellamary, L.; Yazici, Y. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment. Issue 9 (September 2019) Authors: Deshmukh, V.; O'Green, A.L.; Bossard, C.; Seo, T.; Lamangan, L.; Ibanez, M.; Ghias, A.; Lai, C.; Do, L.; Cho, S.; Cahiwat, J.; Chiu, K.; Pedraza, M.; Anderson, S.; Harris, R.; Dellamary, L.; KC, S.; Barroga, C.; Melchior, B.; Tam, B. Journal: Osteoarthritis and cartilage Issue: Volume 27:Issue 9(2019) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The ULK1 inhibitor ENV-201 impairs tumor growth in KRAS-driven flank xenografts as a single agent and in combination with the KRAS inhibitor adagrasib. (October 2022) Authors: Pitman, J.; Dellamary, L.; Kc, S.; de los Rios, M.; Hood, J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗